Paragon Capital Management (Kansas)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $204K | Buy |
|
|||||
|
2023
Q2 | $204K | Sell |
|
|||||
|
2023
Q1 | $236K | Buy |
|
|||||
|
2022
Q4 | $268K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $204K | Sell |
|
|||||
|
2022
Q1 | $210K | Buy |
|
|||||
|
2021
Q4 | $237K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $103K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $114K | Sell |
|
|||||
|
2019
Q2 | $180K | Sell |
|
|||||
|
2019
Q1 | $180K | Sell |
|
|||||
|
2018
Q4 | $203K | Sell |
|
|||||
|
2018
Q3 | $308K | Buy |
|
|||||
|
2018
Q2 | $221K | Sell |
|
|||||
|
2018
Q1 | $301K | Buy |
|
|||||
|
2017
Q4 | $269K | Hold |
|
|||||
|
2017
Q3 | $265K | Buy |
|
|||||
|
2017
Q2 | $250K | Buy |
|
|||||
|
2017
Q1 | $222K | Sell |
|
|||||
|
2016
Q4 | $218K | Buy |
|
|||||
|
2016
Q3 | $215K | Sell |
|
|||||
|
2016
Q2 | $263K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $225K | Sell |
|
|||||
|
2015
Q3 | $222K | Buy |
|
|||||
|
2015
Q2 | $230K | Sell |
|
|||||
|
2015
Q1 | $245K | Sell |
|
|||||
|
2014
Q4 | $223K | Sell |
|
|||||
|
2014
Q3 | $260K | Buy |
|
|||||
|
2014
Q2 | $240K | Sell |
|
|||||
|
2014
Q1 | $278K | Buy |
|
|||||
|
2013
Q4 | $264K | Sell |
|
|||||
|
2013
Q3 | $296K | Buy |
|
|||||
|
2013
Q2 | $271 | Buy |
|